Indication

Vulvovaginal candidiasis

Vulvovaginal candidiasis is an opportunistic fungal infection of the lower female reproductive tract, primarily involving the vaginal mucosa and vulvar epithelium. Read more about Vulvovaginal candidiasis

248 drugs 85 manufacturers

Advertisement

Drugs that treat it

Common Vulvovaginal candidiasis therapies.

Showing 118–126 of 248 drugs

FLUCONAZOLE

ANTIFUNGALS-SYSTEMIC·ORAL CANDIDIASIS·+11
GEN-SOURCE RX

FLUCONAZOLE

ANTIFUNGALS-SYSTEMIC·ORAL CANDIDIASIS·+11
Major Pharamceuticals

FLUCONAZOLE

ANTIFUNGALS-SYSTEMIC·ORAL CANDIDIASIS·+11
HARRIS PHARM
Filter & compare in the drug finder →Opens the drug finder with Vulvovaginal candidiasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Vulvovaginal candidiasis.

Vulvovaginal candidiasis is an opportunistic fungal infection of the lower female reproductive tract, primarily involving the vaginal mucosa and vulvar epithelium.

Most frequently caused by an overgrowth of *Candida albicans*, it commonly affects reproductive-aged women when alterations in host vaginal defenses, the local microbiome, or hormone levels trigger a shift from commensal colonization to pathogenic hyphal invasion.

The condition is clinically characterized by intense vulvar pruritus, burning, soreness, dyspareunia, and external dysuria, often accompanied by erythema, edema, and a thick, curd-like white vaginal discharge against a typically normal vaginal pH.

Personalize your experience

Follow Vulvovaginal candidiasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it